Newamsterdam Pharma Company N.V.’s (NAMS) Moving Averages Convergence Divergence (MACD) indicator is 0.18, suggesting Newamsterdam Pharma Company N.V. is a Buy.

Newamsterdam Pharma Company N.V.’s (NAMS) 20-Day exponential moving average is 24.53, while Newamsterdam Pharma Company N.V.’s (NAMS) share price is $23.55, making it a Sell.

Newamsterdam Pharma Company N.V.’s (NAMS) 50-Day exponential moving average is 23.25, while Newamsterdam Pharma Company N.V.’s (NAMS) share price is $23.55, making it a Buy.

Advanced Chart >

NewAmsterdam Pharma Company (NAMS) Pivot Points

Jan 22, 2025, 07:50 AM

Classic

21.16

21.85

22.63

23.32

24.10

24.79

25.57

Fibonacci

21.85

22.41

22.76

23.32

23.88

24.23

24.79

Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

NewAmsterdam Pharma Company (NAMS) Moving Averages

Jan 22, 2025, 07:50 AM

MA5

23.84Sell

23.93Sell

MA10

24.76Sell

24.42Sell

MA20

25.27Sell

24.53Sell

MA50

23.47Buy

23.25Buy

MA100

20.35Buy

21.70Buy

MA200

19.81Buy

21.04Buy

Newamsterdam Pharma Company N.V.’s (NAMS) 10-Day exponential moving average is 24.42, while Newamsterdam Pharma Company N.V.’s (NAMS) share price is $23.55, making it a Sell.

Newamsterdam Pharma Company N.V.’s (NAMS) 100-Day exponential moving average is 21.70, while Newamsterdam Pharma Company N.V.’s (NAMS) share price is $23.55, making it a Buy.

Newamsterdam Pharma Company N.V.’s (NAMS) stock price is $23.55 and Newamsterdam Pharma Company N.V.’s (NAMS) 50-day simple moving average is 23.47, creating a Buy signal.

Newamsterdam Pharma Company N.V.’s (NAMS) stock price is $23.55 and Newamsterdam Pharma Company N.V.’s (NAMS) 100-day simple moving average is 20.35, creating a Buy signal.

Newamsterdam Pharma Company N.V.’s (NAMS) stock price is $23.55 and Newamsterdam Pharma Company N.V.’s (NAMS) 200-day simple moving average is 19.81, creating a Buy signal.

NewAmsterdam Pharma Company (NAMS) Technical Indicators

Jan 22, 2025, 07:50 AM

RSI (14)

44.17

Neutral

STOCH (9,6)

19.51

Buy

STOCHRSI (14)

19.17

Buy

MACD (12,26)

0.18

Buy

ADX (14)

29.47

Neutral

Williams %R

-76.11

Buy

CCI (14)

-157.57

Buy

ATR (14)

1.18

Ultimate Oscillator

35.83

Neutral

ROC

-10.22

Sell

Newamsterdam Pharma Company N.V.’s (NAMS) Relative Strength Index (RSI) is 44.17, creating a Neutral signal.

Newamsterdam Pharma Company N.V.’s (NAMS) Trend Strength Indicator (ADX) is 29.47, creating a Neutral signal.

Newamsterdam Pharma Company N.V.’s (NAMS) Commodity Channel Index (CCI) is -157.57, creating a Buy signal.

Newamsterdam Pharma Company N.V.’s (NAMS) Price Rate of Change (ROC) is -10.22, creating a Sell signal.

Technical Analysis Screener >

Technical Analysis Screener.

Customize your technical analysis to fit your
unique trading strategy with a flexible screener

Try it Now!

FAQ

Is NAMS a Buy, Hold, or Sell?

Based on NAMS’s technical indicators, NAMS is a Buy.

What is NAMS’s RSI (14)?

NAMS’s RSI (14) is 44.17, which suggests NAMS is a Neutral.

What is NAMS’s MACD?

NAMS’s MACD is 0.18, which suggests NAMS is a Buy.

What is NAMS’s 5-day moving average?

NAMS’s 5-day moving average is 23.84, which suggests NAMS is a Sell.

What is NAMS’s 20-day moving average?

NAMS 20-day moving average is 25.27, which suggests NAMS is a Sell.

What is NAMS’s 50-day moving average?

NAMS’s 50-day moving average is 23.47, which suggests NAMS is a Buy.

What is NAMS’s 200-day moving average?

NAMS’s 200-day moving average is 19.81, which suggests NAMS is a Buy.

What is NAMS’s Williams % R (14)?

NAMS’s Williams % R (14) is -76.11, which suggests NAMS is a Buy.

What is NAMS’s CCI (14)?

NAMS’s CCI (14) is -157.57, which suggests NAMS is a Buy.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing